Application of Natural Medicinal Plants Active Ingredients in Oral Squamous Cell Carcinoma

© 2024. The Chinese Journal of Integrated Traditional and Western Medicine Press and Springer-Verlag GmbH Germany, part of Springer Nature..

Oral squamous cell carcinoma (OSCC) is the most common malignant cancer of the head and neck, with high morbidity and mortality, ranking as the sixth most common cancer in the world. The treatment of OSCC is mainly radiotherapy, chemotherapy and surgery, however, the prognosis of patients is still poor and the recurrence rate is high. This paper reviews the range of effects of natural medicinal plant active ingredients (NMPAIs) on OSCC cancer, including the types of NMPAIs, anti-cancer mechanisms, involved signaling pathways, and clinical trials. The NMPAIs include terpenoids, phenols, flavonoids, glycosides, alkaloids, coumarins, and volatile oils. These active ingredients inhibit proliferation, induce apoptosis and autophagy, inhibit migration and invasion of OSCC cells, and regulate cancer immunity to exert anti-cancer effects. The mechanism involves signaling pathways such as mitogen-activated protein kinase, phosphatidylinositol 3 kinase/protein kinase B, nuclear factor kappa B, miR-22/WNT1/β-catenin and Nrf2/Keap1. Clinically, NMPAIs can inhibit the growth of OSCC, and the combined drug is more effective. Natural medicinal plants are promising candidates for the treatment of OSCC.

Medienart:

E-Artikel

Erscheinungsjahr:

2024

Erschienen:

2024

Enthalten in:

Zur Gesamtaufnahme - year:2024

Enthalten in:

Chinese journal of integrative medicine - (2024) vom: 12. Apr.

Sprache:

Englisch

Beteiligte Personen:

Ren, Qun-Li [VerfasserIn]
Li, Xiao-Lan [VerfasserIn]
Tian, Tian [VerfasserIn]
Li, Shuang [VerfasserIn]
Shi, Rong-Yi [VerfasserIn]
Wang, Qian [VerfasserIn]
Zhu, Yuan [VerfasserIn]
Wang, Miao [VerfasserIn]
Hu, Huan [VerfasserIn]
Liu, Jian-Guo [VerfasserIn]

Links:

Volltext

Themen:

Active ingredients
Journal Article
Mechanism
Natural medicinal plant
Oral squamous cell carcinoma
Review
Signaling pathway

Anmerkungen:

Date Revised 12.04.2024

published: Print-Electronic

Citation Status Publisher

doi:

10.1007/s11655-024-3804-7

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

NLM370969286